The Universitiy of Leeds, Division of Rheumatic and Musculoskeletal Disease, St James's University Hospital
Welcome,         Profile    Billing    Logout  
 6 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Galdo, Francesco Del
ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.

Recruiting
2/3
240
Europe, Canada, Japan, US, RoW
EFG PH20 SC, PBO
argenx, argenx BV
Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome
12/26
02/27
MINIMISE, NCT04927390 / 2019-004139-21: Mycophenolate in Limited Cutaneous Systemic Sclerosis (-Pilot)

Active, not recruiting
2
120
Europe
Mycophenolate Mofetil 500mg
University College, London, Versus Arthritis
Systemic Sclerosis, Limited Cutaneous Systemic Sclerosis
11/23
04/24
NCT06472362: Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

Not yet recruiting
N/A
1000
Europe
HRCT biomarkers
Royal Brompton & Harefield NHS Foundation Trust, Imperial College London, Royal Free and University College Medical School, The Leeds Teaching Hospitals NHS Trust, Hannover Medical School, University of Siena, Università Politecnica delle Marche, Azienda Ospedaliero Universitaria di Sassari, Bichat Hospital
Systemic Sclerosis
06/25
03/26

Download Options